Remeditex Ventures LLC's Net Worth

$208 Million

Estimate Recalculated Sep 18, 2024 01:01AM EST

Who is Remeditex Ventures LLC

Remeditex Ventures LLC has an estimated net worth of $208 Million. This is based on reported shares across multiple companies, which include Viridian Therapeutics, Inc.\DE, LPATH, INC, Soliton, Inc., Menlo Therapeutics Inc., and BELLICUM PHARMACEUTICALS, INC.

SEC CIK

Remeditex Ventures LLC's CIK is 0001627363

Past Insider Trading and Trends

2014 was Remeditex Ventures LLC's most active year for acquiring shares with 5 total transactions. Remeditex Ventures LLC's most active month to acquire stocks was the month of November. 2014 was Remeditex Ventures LLC's most active year for disposing of shares, totalling 4 transactions. Remeditex Ventures LLC's most active month to dispose stocks was the month of November. 2020 saw Remeditex Ventures LLC paying a total of $999,992.30 for 120,481 shares, this is the most they've acquired in one year. In 2021 Remeditex Ventures LLC cashed out on 9,635,085 shares for a total of $208,242,660.20, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Viridian Therapeutics, Inc.\DE

Investor
Updated Feb 13, 2017
Form 3
Feb 13, 2017
2.71M
Showing 1 results

LPATH, INC

Investor
Updated Dec 30, 2016
Form 4
1.31M
Dec 30, 2016
1.31M
Acq/Dis
Dec 29
Form 3
Dec 29, 2016
Showing 2 results

Soliton, Inc.

Investor
Updated Dec 17, 2021
Form 4
-100.00%
-9.64M
$22.60
-$208.24M
Dec 17, 2021
Disposition
Dec 16
Form 4
1.32%
120.48K
$8.30
$999.99K
Jul 01, 2020
9.21M
Purchase
Jun 30
Form 4
3.55%
326.09K
Oct 15, 2019
9.51M
Purchase
Oct 11
Form 4
7.08%
607.14K
Jun 19, 2019
9.19M
Purchase
Jun 19
Form 3
Apr 03, 2019
8.58M
Showing 5 results

Menlo Therapeutics Inc.

Investor
Updated Jan 24, 2018
Form 3
Jan 24, 2018
1.48M
Showing 1 results

BELLICUM PHARMACEUTICALS, INC

Investor
Updated Dec 23, 2014
Form 4
-39.72%
-1.19M
Dec 23, 2014
1.81M
Options
Dec 23
Form 4
Dec 19, 2014
159.44K
Options
Dec 17
Form 3
Dec 17, 2014
Showing 3 results